BioCentury
ARTICLE | Company News

Alere, Abbott deal

February 8, 2016 8:00 AM UTC

Abbott will acquire diagnostics company Alere for $56 per share in cash, or about $5.8 billion. The price is a 50.5% premium to Alere’s close of $37.20 on Jan. 29, the last trading day before the deal...